Cognitive disorders linked to severe COVID-19 risk

covid-19
Credit: CC0 Public Domain

Dementia and other cognitive disorders now appear to be risk factors for developing severe COVID-19, according to research from the University of Georgia. The findings highlight the need for special care for populations with these preexisting conditions during the pandemic.

In a blind study, the researchers analyzed data from nearly 1,000 diseases and two to compare the health profiles of COVID-19 patients with those testing negative, looking for commonalities in the COVID-19 patients.

The study, published online in the journal Brain, Behavior and Immunity, relied on data from UK Biobank, a long-term study of more than 500,000 participants investigating the respective contributions of genetic predisposition and environmental exposure to the development of disease.

Beginning in March, the UK Biobank started to report the COVID-19 status of its participants. The team in the Franklin College of Arts and Sciences department of genetics, led by assistant professor Kaixiong Ye and his postdoc, Jingqi Zhou, promptly connected the COVID-19 status to the electronic health data.

"We took a hypothesis-free approach and the most statistically significant ones are the and Type 2 diabetes," said Ye, the senior author on the study. "Right now, we don't know the mechanisms behind these associations, we only know these are more common in COVID-19 patients."

Analyzing the that make some individuals at higher risk for severe COVID-19, the team focused on two genes: ACE2 and TPMPRSS2, known to be critical for the virus to enter into human cells.

"In the TMPRSS2 gene we found that a specific genetic variation is more common in the COVID-19 patient," he said, adding that while the discovery was novel at the time, the team knows more data now exists about host genetic factors than even three months ago.

The research team also found that variations in genes related to SARS-CoV-2 infection may be associated with severe COVID-19 that requires hospitalization.

"And we are starting to understand how those genetic variations are making a difference," he said, noting the extraordinary pace of research worldwide during the pandemic as scientists work on SARS CoV 2. Since they began in spring 2020, Ye's group has been able to follow up on its own earlier work and communicate with peers around the world to contribute to the overall body of knowledge about the disease.

"Working on one disease, the whole field is converging together, around the world, at the same time. It really showcases the power of science," Ye said. "What my group is doing is really just , large-scale data mining, but from vaccine development to studies in patients, scientists are attacking the from different aspects, and that's moving us forward very quickly in combating COVID-19."


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: Jingqi Zhou et al, Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study, Brain, Behavior, and Immunity (2020). DOI: 10.1016/j.bbi.2020.10.019
Journal information: Brain, Behavior, and Immunity

Citation: Cognitive disorders linked to severe COVID-19 risk (2020, October 28) retrieved 23 May 2022 from https://medicalxpress.com/news/2020-10-cognitive-disorders-linked-severe-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
11 shares

Feedback to editors